搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
12 小时
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic ...
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm ...
12 小时
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.
21 小时
5 COVID skin rashes: Dermatologists share tips to identify and treat viral skin conditions
We tend to think of COVID-19 as a respiratory illness. But, like many viruses, COVID can also affect your skin and cause ...
22 小时
on MSN
I get carsick, seasick and airsick — here’s how to treat and prevent all kinds of ...
Here are the best ways to treat and prevent motion sickness while traveling. Browse treatments from brands like Dramamine, ...
21 小时
on MSN
Pharmacies are yanking cold medicines from shelves. So what are the options now?
The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
Knowridge
5 小时
What causes the itch in mosquito bites? And why do some people get such a bad reaction
Are you one of these people who loathes spending time outdoors at dusk as the weather warms and mosquitoes start biting?
manilatimes
3 小时
Iqirvo® (elafibranor) data shows efficacy and safety for up to 3 years in patients with ...
No new safety findings were observed. The most common treatment-emergent adverse events (>10 percent) occurring more ...
3 小时
Ipsen Pharma: Iqirvo (elafibranor) data shows efficacy and safety for up to 3 years in ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September 202 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈